Alastair Canaway and Chris Sampson look at a new PSSRU report on youth mental health services in the UK, and how they affect health, education and employment.
[read the full story...]
Chris Sampson looks at a systematic review of the economics of Internet interventions for common mental health problems such as depression and anxiety.
[read the full story...]
Can we steer drug-using offenders away from crime and into treatment? Chris Sampson explores a study of the cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs.
[read the full story...]
Susie Johnson reports on the FolATED RCT and economic evaluation of folic acid for depression. The study finds no evidence that folic acid is clinically effective or cost-effective in augmenting antidepressants and speculates instead that methylfolate may be a better candidate for future research.
[read the full story...]
Our resident Elf Economist, Chris Sampson, reports on a new systematic review of economic evaluations for borderline personality disorder. Are any cost-effective?
[read the full story...]
Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.
[read the full story...]
Andrew Jones and Chris Sampson report on a systematic review and economic evaluation of cytisine and varenicline for smoking cessation, which finds that both drugs are clinically effective compared with placebo.
[read the full story...]
Elf economist Chris Sampson reports on the economic evaluation of the CoBalT RCT, which finds that CBT is cost-effective for treatment resistant depression in primary care.
[read the full story...]
Chris Sampson looks at the economic outcomes of a recent RCT of joint crisis plans to reduce compulsory treatment for people with psychosis. The study reports the potential for gains specifically among Black patients.
[read the full story...]
Health Economist Christopher Sampson reports on a recent systematic review and meta-analysis, which shows health-related quality of life utility values vary between studies and economic models should consider this.
[read the full story...]
